Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA rejects expanded use of Regeneron drug for gout
Reuters
Tuesday, July 31, 2012 - 11:06am
tags:
Regeneron, gout, FDA, Arcalyst
Arena Pharmaceuticals transfers diet pill marketing rights to Japanese partner Eisai
Yahoo/AP
Monday, July 30, 2012 - 12:23pm
tags:
Belviq, Arena Pharmaceuticals, Eisai
Acura sinks on Pfizer deal termination
Marketwatch
Monday, July 30, 2012 - 12:22pm
tags:
Pfizer, Acura Pharmaceuticals
Osiris Therapeutics takes 2Q loss as payments fall
Yahoo/AP
Monday, July 30, 2012 - 11:45am
tags:
earnings, Osiris
Roche Building On Its Strengths
Seeking Alpha
Monday, July 30, 2012 - 11:44am
tags:
Roche, Abbott Labs, AstraZeneca, Gilead, Complete Genomics, Sanofi, Pfizer, Pacific Biosciences, JNJ, Novartis, Illumina, GSK
Senesco’s Lead Therapeutic Candidate, SNS01-T, Granted Orphan Drug Status from FDA for Treatment of Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
Yahoo
Monday, July 30, 2012 - 11:06am
tags:
Senesco, SNS01-T, orphan drugs, mantle cell lymphoma, diffuse large B-cell lymphoma
Advaxis reports updated Phase 2 cervical cancer trial data
Yahoo/Fly on the Wall
Monday, July 30, 2012 - 11:04am
tags:
Advaxis, cervical cancer, ADXS-HPV
FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
Yahoo
Monday, July 30, 2012 - 11:00am
tags:
FDA, cabozantinib, medullary thyroid cancer, Exelixis
What To Expect For The Future Of Celgene
Seeking Alpha
Monday, July 30, 2012 - 10:58am
tags:
Celgene
Progenics Plummets On Rejection Of New Use Of Relistor Drug
Bloomberg
Monday, July 30, 2012 - 10:57am
tags:
Progenics Pharmaceuticals, Relistor, Salix, opiod-induced constipation
Rituxan And Its Biosimilar Competitors
Seeking Alpha
Monday, July 30, 2012 - 10:28am
tags:
Rituxan, BiogenIdec, Halozyme, Hospira, iBio, Lonza, Merck, Novartis, Pfizer, Roche, Spectrum Pharmaceuticals, cancer, Viropro, Teva Pharmaceuticals
Gilead Sciences Firing On All Cylinders
TheStreet.com
Monday, July 30, 2012 - 10:26am
tags:
Gilead, GSK, Bristol-Myers Squibb
Novartis drug Afinitor gets EU nod for breast cancer
Reuters
Monday, July 30, 2012 - 10:25am
tags:
Afinitor, Novartis, breast cancer, Europe
4 Reasons To Buy AcelRx Pharmaceuticals
Seeking Alpha
Monday, July 30, 2012 - 10:24am
tags:
AcelRx
Pfizer Earnings Preview: A Pharma Giant Descends From Growth To Value Status
Seeking Alpha
Monday, July 30, 2012 - 10:23am
tags:
earnings, Pfizer
Acura Pharma's Earnings Rescheduled For Monday's Close, With Tuesday Conference Call
Seeking Alpha
Sunday, July 29, 2012 - 1:18pm
tags:
Acura Pharmaceuticals, earnings
Investment Insider: Pharmaceutical industry's best years lie ahead
Independent, UK
Sunday, July 29, 2012 - 1:18pm
tags:
Major Insider Buying And Diversified Pipeline Has Me Interested In This Speculative Drug Stock
Seeking Alpha
Sunday, July 29, 2012 - 1:16pm
tags:
Furiex Pharmaceuticals
Lupin looks to acquire brands in the US; eyes 20% growth
Economic Times, India
Sunday, July 29, 2012 - 1:15pm
tags:
Lupin
Angiotech Pharmaceuticals, Inc. Amends Exchange Offer and Consent Solicitation for its Senior Floating Rate Notes Due 2013
Sacramento Bee, CA
Sunday, July 29, 2012 - 1:14pm
tags:
Angiotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.